Dhanekula Nitesh D, Crouch Gareth, Byth Karen, Lau Sue Lynn, Kim Albert, Graham Edward, Ellis Andrew, Clifton-Bligh Roderick J, Girgis Christian M
Faculty of Medicine and Health University of Sydney Sydney Australia.
Department of Orthopaedic Surgery Westmead Hospital Westmead Australia.
JBMR Plus. 2022 Feb 17;6(4):e10607. doi: 10.1002/jbm4.10607. eCollection 2022 Apr.
The earliest reports of atypical femur fractures (AFF) emerged from Asia. In the West, epidemiologic studies report a greater incidence of AFFs among subjects of Asian background. Asian ethnicity is an established risk factor for AFF, but clear mechanisms to explain this risk and implications for the general development of AFF are open questions. Ethno-specific differences in bisphosphonate action and femoral geometry have been proposed as hypotheses. In a retrospective cohort of 163 female patients presenting with AFFs or typical femur fractures (TFF), relative contributions of Asian ethnicity, proximal femoral geometry, and bisphosphonate use in AFF status were examined. There was a fourfold higher proportion of Asian subjects in the AFF compared with TFF groups (31.6%, 30/95 versus 7.4%, 5/68). Asian subjects had smaller femurs in femoral head, neck, and axial dimensions. A multiple logistic regression model for AFF status was fitted adding Asian ethnicity to three previously reported independent predictors of AFF including femoral geometry, which together comprise the Sydney AFF Score (age ≤80 years, femoral neck width <37 mm than non-Asian, lateral cortical width at lesser trochanter ≥5 mm). Asian ethnicity was a robust independent predictor of AFF, imparting sevenfold increase in the odds of AFF after adjusting for all three variables (95% confidence interval [CI] 2.2-23.2, = 0.001) or for overall AFF score (95% CI 2.2-22.3 = 0.001). Overall Asian subjects had higher rates of bisphosphonate use than non-Asian subjects (67.6% versus 47.2%, = 0.034). Among AFF bisphosphonate users, Asian subjects had lower AFF scores than non-Asians (Sydney AFF Score ≤1, 45.5% Asian subjects versus 22.2% non-Asian subjects, = 0.05). Asian ethnicity is a strong independent risk factor for AFF, unaccounted for by ethno-specific differences in proximal femoral geometry. Bisphosphonate use may be associated with a greater predisposition for AFF in Asian subjects compared with non-Asian subjects. © 2022 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
非典型股骨骨折(AFF)的最早报道来自亚洲。在西方,流行病学研究报告称,亚洲背景的受试者中AFF的发病率更高。亚洲人种是AFF的既定风险因素,但解释这种风险的明确机制以及对AFF总体发展的影响仍是悬而未决的问题。双膦酸盐作用和股骨几何形状的种族特异性差异已被提出作为假设。在一项对163例出现AFF或典型股骨骨折(TFF)的女性患者的回顾性队列研究中,研究了亚洲人种、股骨近端几何形状和双膦酸盐使用对AFF状态的相对影响。与TFF组相比,AFF组中亚洲受试者的比例高出四倍(31.6%,30/95对7.4%,5/68)。亚洲受试者的股骨头、颈和轴向尺寸的股骨较小。建立了一个AFF状态的多元逻辑回归模型,将亚洲人种添加到先前报道的三个AFF独立预测因素中,包括股骨几何形状,这三个因素共同构成悉尼AFF评分(年龄≤80岁,股骨颈宽度<37mm相比于非亚洲人,小转子处外侧皮质宽度≥5mm)。亚洲人种是AFF的有力独立预测因素,在对所有三个变量进行调整后,AFF的几率增加了七倍(95%置信区间[CI]2.2 - 23.2,P = 0.001),或对总体AFF评分而言(95%CI 2.2 - 22.3,P = 0.001)。总体而言,亚洲受试者双膦酸盐的使用率高于非亚洲受试者(67.6%对47.2%,P = 0.034)。在使用双膦酸盐的AFF患者中,亚洲受试者的AFF评分低于非亚洲人(悉尼AFF评分≤1,亚洲受试者为45.5%,非亚洲受试者为22.2%)。亚洲人种是AFF的一个强大独立风险因素,股骨近端几何形状的种族特异性差异无法解释这一因素。与非亚洲受试者相比,亚洲受试者使用双膦酸盐可能更容易发生AFF。© 2022作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。